Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine.
paper
Cited
Public
Unavailable
- Authors
- Sofuoglu, Mehmet; Herman, Aryeh I; Nadim, Haleh; Jatlow, Peter
- Year
- 2012
- Journal
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- PMID
- 22334123
- DOI
- 10.1038/npp.2011.336
- PMCID
- PMC3327855
The ratio of nicotine metabolites (trans-3'-hydroxycotinine (3HC) to cotinine) correlates with nicotine clearance. In previous studies, high nicotine metabolite ratio (NMR) predicted poor outcomes for smoking cessation treatment with nicotine patch. The underlying mechanisms that associate NMR with treatment outcomes have not been fully elucidated. A total of 100 smokers were divided into quartiles based on their baseline plasma NMR. Following overnight abstinence, smokers received saline followed by escalating intravenous doses of nicotine (0.5 and 1.0 mg/70 kg) given 30 min apart. The effects of nicotine on subjective, plasma cortisol, heart rate, and systolic and diastolic blood pressure measures were obtained. Smokers in the first NMR quartile (slower metabolizers) had lower Fagerstrom Test for Nicotine Dependence (FTND) scores, suggesting lower levels of dependence. In contrast, smokers in the fourth NMR quartile (faster metabolizers) reported greater craving for cigarettes following overnight abstinence from smoking and reported greater ratings of nicotine-induced good drug effects, drug liking, and wanting more drug. Higher NMR was also associated with greater heart rate increases in response to nicotine. These results suggest that enhanced nicotine reward and cigarette craving may contribute to the poor treatment response in smokers with high NMR. These findings warrant further investigation, especially in treatment-seeking smokers undergoing cessation treatment.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A multi-site study examining the tobacco withdrawal trajectory in people with tobacco and cannabis co-use. | Rabin RA et al. | — | 2025 | → |
| A phenome-wide association study of genetically determined nicotine metabolism reveals novel links with health-related outcomes. | Buchwald J et al. | — | 2025 | → |
| Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation. | Durairaj P et al. | — | 2025 | → |
| Estimating the health impact of nicotine exposure by dissecting the effects of nicotine versus non-nicotine constituents of tobacco smoke: A multivariable Mendelian randomisation study. | Khouja JN et al. | — | 2024 | → |
| Exploring the role of nicotine and smoking in sleep behaviours: A multivariable Mendelian Randomisation study | Page S et al. | — | 2024 | — |
| Relationships Between the Nicotine Metabolite Ratio and Laboratory Assessments of Smoking Reinforcement and Craving Among Adults in a Smoking Cessation Trial. | Cooper RK et al. | — | 2024 | → |
| Can Treatment Support Mitigate Nicotine Metabolism-Based Disparities in Smoking Abstinence? Secondary Analysis of the Helping HAND 4 Trial. | Lee SS et al. | — | 2023 | → |
| Examining racial differences in smoking outcomes among smokers enrolled in an intravenous nicotine infusion study. | Schwartz EKC et al. | — | 2023 | → |
| Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success. | Chenoweth MJ et al. | — | 2023 | → |
| Nicotine flux as a powerful tool for regulating nicotine delivery from e-cigarettes: Protocol of two complimentary randomized crossover clinical trials. | El-Hellani A et al. | — | 2023 | → |
| Preliminary assessment of the subjective effects of electronic-cigarettes in young-adult low-dose electronic-cigarette users: Effects of nicotine dose and e-liquid flavor. | Peterson ML et al. | — | 2023 | → |
| The importance of translationally evaluating steroid hormone contributions to substance use. | Maher EE et al. | — | 2023 | → |
| Threshold for the pleasurable effects of nicotine are lower than its reinforcing effects during self-administration. | MacLean RR et al. | — | 2023 | → |
| Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective. | Archie SR et al. | — | 2022 | → |
| Contributions of chronic tobacco smoking to HIV-associated brain atrophy and cognitive deficits. | Liang HJ et al. | — | 2022 | → |
| Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation. | Li H et al. | — | 2022 | → |
| Genetic differences in nicotine sensitivity and metabolism in C57BL/6J and NOD/ShiLtJ mouse strains. | Seemiller LR et al. | — | 2022 | → |
| Nicotine Patch Alters Patterns of Cigarette Smoking-Induced Dopamine Release: Patterns Relate to Biomarkers Associated With Treatment Response. | Zakiniaeiz Y et al. | — | 2022 | → |
| Plasma Menthol Glucuronide as a Biomarker for the Behavioral Effects of Menthol and Nicotine in Humans. | Gueorguieva R et al. | — | 2022 | → |
| Acute effects of a very low nicotine content cigarette on laboratory smoking lapse: Impacts of nicotine metabolism and nicotine dependence. | Schlagintweit HE et al. | — | 2021 | → |
| Acute effects of inhaled menthol on cognitive effects of intravenous nicotine among young adult cigarette smokers. | Jao NC et al. | — | 2021 | → |
| Impact of CYP2A6 Activity on Nicotine Reinforcement and Cue-Reactivity in Daily Smokers. | Butler K et al. | — | 2021 | → |
| Influence of menthol and green apple e-liquids containing different nicotine concentrations among youth e-cigarette users. | Jackson A et al. | — | 2021 | → |
| Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism. | Perez-Paramo YX et al. | — | 2021 | → |
| Racial/ethnic differences in perceived risks and benefits of quitting smoking in a sample of African American and Hispanic adults living with HIV/AIDS: A preliminary study. | Weinberger AH et al. | — | 2021 | → |
| Smoke at night and sleep worse? The associations between cigarette smoking with insomnia severity and sleep duration. | Nuñez A et al. | — | 2021 | → |
| The effects of inhaled flavors on intravenous nicotine. | MacLean RR et al. | — | 2021 | → |
| Threshold dose for intravenous nicotine self-administration in young adult non-dependent smokers. | MacLean RR et al. | — | 2021 | → |
| Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations. | El-Boraie A et al. | — | 2021 | → |
| Differential effects of nicotine delivery rate on subjective drug effects, urges to smoke, heart rate and blood pressure in tobacco smokers. | Jensen KP et al. | — | 2020 | → |
| Effects of Nicotine Metabolic Rate on Cigarette Reinforcement. | Liakoni E et al. | — | 2020 | → |
| Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. | El-Boraie A et al. | — | 2020 | → |
| Independent and Combined Effects of Nicotine or Chronic Tobacco Smoking and HIV on the Brain: A Review of Preclinical and Clinical Studies. | Chang L et al. | — | 2020 | → |
| Modulation of "Protective" Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-cigarettes. | DeVito EE et al. | — | 2020 | → |
| Nicotine Effects, Body Weight Concerns and Smoking: A Literature Review. | Cepeda-Benito A | — | 2020 | → |
| Opioid Use and Rate of Nicotine Metabolism Among Pregnant Smokers. | Oncken C et al. | — | 2020 | → |
| The influence of nicotine metabolic rate on working memory over 6 hours of abstinence from nicotine. | Nardone N et al. | — | 2020 | → |
| The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. | Siegel SD et al. | — | 2020 | → |
| Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence. | Schuster RM et al. | — | 2020 | → |
| Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research. | Schnoll RA et al. | — | 2019 | → |
| Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline. | Tomaz PRX et al. | — | 2019 | → |
| Differences in the rate of nicotine metabolism among smokers with and without HIV. | Ashare RL et al. | — | 2019 | → |
| Drug-induced stress responses and addiction risk and relapse. | Wemm SE et al. | — | 2019 | → |
| Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence. | Liakoni E et al. | — | 2019 | → |
| Not all smokers appear to seek nicotine for the same reasons: implications for preclinical research in nicotine dependence. | Garcia-Rivas V et al. | — | 2019 | → |
| Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions. | Allen AM et al. | — | 2019 | → |
| Reinforcement Enhancing Effects of Nicotine Via Patch and Nasal Spray. | Perkins KA et al. | — | 2019 | → |
| Acute effects of inhaled menthol on the rewarding effects of intravenous nicotine in smokers. | Valentine GW et al. | — | 2018 | → |
| Biochemical, demographic, and self-reported tobacco-related predictors of the acute heart rate response to nicotine in smokers. | Jensen KP et al. | — | 2018 | → |
| E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure. | DeVito EE et al. | — | 2018 | → |
| Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. | Chenoweth MJ et al. | — | 2018 | → |
| Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives. | Allen AM et al. | — | 2018 | → |
| Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity. | Valentine GW et al. | — | 2018 | → |
| Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers. | Di Ciano P et al. | — | 2018 | → |
| Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. | Tanner JA et al. | — | 2018 | → |
| Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. | Bozinoff N et al. | — | 2018 | → |
| Use of Electronic Cigarettes Leads to Significant Beta2-Nicotinic Acetylcholine Receptor Occupancy: Evidence From a PET Imaging Study. | Baldassarri SR et al. | — | 2018 | → |
| Use of hormonal contraceptives and smoking cessation: A preliminary report. | Allen AM et al. | — | 2018 | → |
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | Jensen KP et al. | — | 2017 | → |
| Characterising the nicotine metabolite ratio and its association with treatment choice: A cross sectional analysis of Stop Smoking Services in England. | Shahab L et al. | — | 2017 | → |
| Menthol disrupts nicotine's psychostimulant properties in an age and sex-dependent manner in C57BL/6J mice. | Fait BW et al. | — | 2017 | → |
| Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency. | Gubner NR et al. | — | 2017 | → |
| Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries. | Fix BV et al. | — | 2017 | → |
| Pharmacogenetic Optimization of Smoking Cessation Treatment. | Chenoweth MJ et al. | — | 2017 | → |
| Quit Intentions Moderate Subjective and Physiological Responses to Acute Nicotine Replacement Therapy Administration in Dependent Smokers. | Schlagintweit HE et al. | — | 2017 | → |
| Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. | Faulkner P et al. | — | 2017 | → |
| Studying the interactive effects of menthol and nicotine among youth: An examination using e-cigarettes. | Krishnan-Sarin S et al. | — | 2017 | → |
| Variation in CYP2A6 Activity and Personalized Medicine. | Tanner JA et al. | — | 2017 | → |
| Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population. | Li H et al. | — | 2016 | → |
| Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate. | Falcone M et al. | — | 2016 | → |
| Cessation of alcohol consumption decreases rate of nicotine metabolism in male alcohol-dependent smokers. | Gubner NR et al. | — | 2016 | → |
| Effect of Menthol-preferring Status on Response to Intravenous Nicotine. | DeVito EE et al. | — | 2016 | → |
| Nicotine Dependence and Urinary Nicotine, Cotinine and Hydroxycotinine Levels in Daily Smokers. | Van Overmeire IP et al. | — | 2016 | → |
| Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio. | Allenby CE et al. | — | 2016 | → |
| The effects of alcohol-containing e-cigarettes on young adult smokers. | Valentine GW et al. | — | 2016 | → |
| The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. | Chenoweth MJ et al. | — | 2016 | → |
| Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers. | Chenoweth MJ et al. | — | 2016 | → |
| A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans. | Jensen KP et al. | — | 2015 | → |
| Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. | Mamoun M et al. | — | 2015 | → |
| Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. | Linneberg A et al. | — | 2015 | → |
| FKBP5 variation is associated with the acute and chronic effects of nicotine. | Jensen KP et al. | — | 2015 | → |
| Pharmacogenetics of nicotine and associated smoking behaviors. | Tanner JA et al. | — | 2015 | → |
| Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. | Weinberger AH et al. | — | 2015 | → |
| Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. | Lerman C et al. | — | 2015 | → |
| Accuracy of prenatal smoking data from Washington State birth certificates in a population-based sample with cotinine measurements. | Searles Nielsen S et al. | — | 2014 | → |
| Cadmium increases the sensitivity of adolescent female mice to nicotine-related behavioral deficits. | Adeniyi PA et al. | — | 2014 | → |
| Finding genomic function for genetic associations in nicotine addiction research: the ENCODE project's role in future pharmacogenomic analysis. | Vandenbergh DJ et al. | — | 2014 | → |
| Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. | Chenoweth MJ et al. | — | 2014 | → |
| Nicotine-Cadmium Interaction Alters Exploratory Motor Function and Increased Anxiety in Adult Male Mice. | Chris Ajonijebu D et al. | — | 2014 | → |
| Pharmacogenetics of nicotine addiction: role of dopamine. | Herman AI et al. | — | 2014 | → |
| Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase. | DeVito EE et al. | — | 2014 | → |
| Age-related differences in the disposition of nicotine and metabolites in rat brain and plasma. | Vieira-Brock PL et al. | — | 2013 | → |
| Biomarkers for smoking cessation. | Bough KJ et al. | — | 2013 | → |
| COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers. | Herman AI et al. | — | 2013 | → |
| The drug effects questionnaire: psychometric support across three drug types. | Morean ME et al. | — | 2013 | → |